Stryker logo

Stryker share price today

(SYK)

Stryker share price is $366.49 & ₹31,186.47 as on 25 Dec 2024, 2.30 'hrs' IST

$366.49

1.89

(0.52%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Stryker share price in Dollar and Rupees. Guide to invest in Stryker from India. Also see the sentimental analysis on Indian investors investing in Stryker. Get details on the Indian mutual funds that are investing in Stryker. Get Analyst recommendations and forecasts along with all the Stryker's financials.

Stryker share price movements

  • Today's Low: $362.77
    Today's High: $367.16

    Day's Volatility :1.2%

  • 52 Weeks Low: $292.43
    52 Weeks High: $398.20

    52 Weeks Volatility :26.56%

Stryker Returns

PeriodStryker CorporationSector (Health Care)S&P500
3 Months
1.0%
-10.6%
3.7%
6 Months
7.38%
-6.0%
8.5%
1 Year
21.91%
2.2%
24.7%
3 Years
34.83%
-0.9%
25.5%

Stryker Key Statistics

in dollars & INR

Previous Close
$364.6
Open
$364.79
Today's High
$367.16
Today's Low
$362.765
Market Capitalization
$136.1B
Today's Volume
$2.9M
52 Week High
$398.2
52 Week Low
$292.43
Revenue TTM
$22.0B
EBITDA
$5.7B
Earnings Per Share (EPS)
$9.32
PE Ratio
38.32
Dividend Yield
0.94%
Profit Margin
16.34%
Quarterly Earnings Growth YOY
0.2%
Return On Equity TTM
18.87%

How to invest in Stryker from India?

It is very easy for Indian residents to invest directly in Stryker from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Stryker stock in both Indian Rupees (INR) and US Dollars (USD). Search for Stryker or SYK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Stryker or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Stryker shares which would translate to 0.002 fractional shares of Stryker as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Stryker, in just a few clicks!

Returns in Stryker for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Stryker investment value today

Current value as on today

₹1,24,882

Returns

₹24,882

(+24.88%)

Returns from Stryker Stock

₹22,543 (+22.54%)

Dollar Returns

₹2,339 (+2.34%)

Indian investors sentiment towards Stryker

2.13%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Investment in Stryker from India has grown in the last 30 days as on Dec 24, 2024. 2.13% more purchase transactions for Stryker in the last 30 days versus the previous period.

-23%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Stryker on INDmoney from India has reduced in the last 30 days as on Dec 24, 2024. -23% less investors are searching Stryker in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Stryker

Global Institutional Holdings in Stryker

  • Vanguard Group Inc

    8.51%

  • BlackRock Inc

    7.03%

  • Greenleaf Trust

    4.86%

  • State Street Corp

    3.83%

  • T. Rowe Price Associates, Inc.

    2.90%

  • JPMorgan Chase & Co

    2.84%

Analyst Recommendation on Stryker

Buy

    67%Buy

    32%Hold

    0%Sell

Based on 34 Wall street analysts offering stock ratings for Stryker(by analysts ranked 0 to 5 stars)

Based on 34 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
23
23
22
Hold
11
11
11
Sell
0
0
0

Analyst Forecast on Stryker

What analysts predicted

Upside of 10.45%

Current:

$366.49

Target:

$404.78

Insights on Stryker

  • Price Movement

    In the last 3 years, SYK stock has moved up by 35.9%
  • Increasing Revenue

    Stryker Corporation has shown positive revenue growth over the last three quarters. Their revenue increased from $5.24 billion to $5.49 billion, reflecting an average increase of 2.3% per quarter.
  • Increasing Net Profit

    Stryker Corporation has seen a positive trend in its net profit over the last three quarters. Specifically, the net profit increased from $788.0 million to $834.0 million, which reflects an average growth of 2.8% per quarter.
  • SYK vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 59.1% return, outperforming this stock by 36.5%
  • SYK vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 108.2% return, outperforming this stock by 72.3%
  • Price to Sales

    Stryker Corporation (SYK) has a Price-to-Sales Ratio of 6.3, meaning that investors are willing to pay $6.3 for every $1 of sales the company generates. In comparison, Boston Scientific Corp. has a higher Price-to-Sales Ratio of 8.2, indicating that investors are paying more for each dollar of sales from that company.

Stryker Financials in INR & Dollars

FY18Y/Y Change
Revenue
$13.6B
↑ 9.3%
Net Income
$3.6B
↑ 248.33%
Net Profit Margin
26.12%
↑ 17.92%
FY19Y/Y Change
Revenue
$14.9B
↑ 9.43%
Net Income
$2.1B
↓ 41.37%
Net Profit Margin
13.99%
↓ 12.13%
FY20Y/Y Change
Revenue
$14.4B
↓ 3.58%
Net Income
$1.6B
↓ 23.24%
Net Profit Margin
11.14%
↓ 2.85%
FY21Y/Y Change
Revenue
$17.1B
↑ 19.21%
Net Income
$2.0B
↑ 24.7%
Net Profit Margin
11.66%
↑ 0.52%
FY22Y/Y Change
Revenue
$18.4B
↑ 7.84%
Net Income
$2.4B
↑ 18.25%
Net Profit Margin
12.78%
↑ 1.12%
FY23Y/Y Change
Revenue
$20.5B
↑ 11.11%
Net Income
$3.2B
↑ 34.22%
Net Profit Margin
15.44%
↑ 2.66%
Q2 FY23Q/Q Change
Revenue
$5.0B
↑ 4.56%
Net Income
$738.0M
↑ 24.66%
Net Profit Margin
14.77%
↑ 2.38%
Q3 FY23Q/Q Change
Revenue
$4.9B
↓ 1.74%
Net Income
$692.0M
↓ 6.23%
Net Profit Margin
14.1%
↓ 0.67%
Q4 FY23Q/Q Change
Revenue
$5.8B
↑ 18.46%
Net Income
$1.1B
↑ 65.17%
Net Profit Margin
19.66%
↑ 5.56%
Q1 FY24Q/Q Change
Revenue
$5.2B
↓ 9.84%
Net Income
$788.0M
↓ 31.06%
Net Profit Margin
15.03%
↓ 4.63%
Q2 FY24Q/Q Change
Revenue
$5.4B
↑ 3.41%
Net Income
$825.0M
↑ 4.7%
Net Profit Margin
15.22%
↑ 0.19%
Q3 FY24Q/Q Change
Revenue
$5.5B
↑ 1.33%
Net Income
$834.0M
↑ 1.09%
Net Profit Margin
15.18%
↓ 0.04%
FY18Y/Y Change
Profit
$8.9B
↑ 9.36%
FY19Y/Y Change
Profit
$9.7B
↑ 8.48%
FY20Y/Y Change
Profit
$9.1B
↓ 6.59%
FY21Y/Y Change
Profit
$11.0B
↑ 21.1%
FY22Y/Y Change
Profit
$11.6B
↑ 5.56%
FY23Y/Y Change
Profit
$13.1B
↑ 13.12%
Q2 FY23Q/Q Change
Profit
$3.2B
↑ 5.47%
Q3 FY23Q/Q Change
Profit
$3.2B
↓ 0.72%
Q4 FY23Q/Q Change
Profit
$3.7B
↑ 17.26%
Q1 FY24Q/Q Change
Profit
$3.2B
↓ 14.02%
Q2 FY24Q/Q Change
Profit
$3.3B
↑ 4.4%
Q3 FY24Q/Q Change
Profit
$3.5B
↑ 5.81%
FY18Y/Y Change
Operating Cash Flow
$2.6B
↑ 67.42%
Investing Cash Flow
$-2.9B
↑ 77.12%
Financing Cash Flow
$1.3B
↓ 267.38%
FY19Y/Y Change
Operating Cash Flow
$2.2B
↓ 16.05%
Investing Cash Flow
$-1.5B
↓ 49.07%
Financing Cash Flow
$3.0M
↓ 99.77%
FY20Y/Y Change
Operating Cash Flow
$3.3B
↑ 49.57%
Investing Cash Flow
$-4.7B
↑ 223.09%
Financing Cash Flow
$-11.0M
↓ 466.67%
FY21Y/Y Change
Operating Cash Flow
$3.3B
↓ 0.43%
Investing Cash Flow
$-859.0M
↓ 81.73%
Financing Cash Flow
$-2.4B
↑ 21400.0%
FY22Y/Y Change
Operating Cash Flow
$2.6B
↓ 19.58%
Investing Cash Flow
$-2.9B
↑ 240.4%
Financing Cash Flow
$-749.0M
↓ 68.33%
Q2 FY23Q/Q Change
Operating Cash Flow
$688.0M
↑ 54.61%
Investing Cash Flow
$-533.0M
↑ 303.79%
Financing Cash Flow
$-405.0M
↓ 15.8%
Q3 FY23Q/Q Change
Operating Cash Flow
$1.1B
↑ 52.62%
Investing Cash Flow
$-810.0M
↑ 51.97%
Financing Cash Flow
$-422.0M
↑ 4.2%

Stryker Technicals Summary

Sell

Neutral

Buy

Stryker is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Stryker Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Stryker Corporation
-5.28%
7.38%
21.91%
34.83%
73.83%
Boston Scientific Corp.
-0.34%
14.76%
58.87%
106.28%
96.53%
Edwards Lifesciences Corp.
4.97%
-17.86%
-1.93%
-42.71%
-4.81%
Abbott Laboratories
-3.3%
8.29%
4.58%
-19.25%
30.88%
Medtronic Plc
-5.5%
0.77%
-1.54%
-22.41%
-28.02%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Stryker Corporation
38.32
38.32
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.27
73.27
1.61
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.88
28.88
6.79
2.55
0.19
0.11
NA
16.18
Abbott Laboratories
34.17
34.17
2.17
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.46
24.46
1.46
5.2
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Stryker Corporation
Buy
$136.1B
73.83%
38.32
16.34%
Boston Scientific Corp.
Buy
$130.7B
96.53%
73.27
11.26%
Edwards Lifesciences Corp.
Buy
$44.1B
-4.81%
28.88
65.86%
Abbott Laboratories
Buy
$195.0B
30.88%
34.17
13.99%
Medtronic Plc
Buy
$102.6B
-28.02%
24.46
12.06%

Stryker Dividend announcements

  • Stryker Dividends December, 2024

    In the quarter ending December,2024. Stryker has declared dividend of $0.84

    Read More

About Stryker

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
Organization
Stryker
Employees
52000
CEO
Mr. Kevin A. Lobo
Industry
Health Technology

Management People of Stryker

NameTitle
Mr. Kevin A. Lobo
Chairman, CEO & President
Mr. Glenn S. Boehnlein CPA
VP & CFO
Mr. Viju S. Menon
Group President of Global Quality & Operations
Mr. J. Andrew Pierce
Group President of MedSurg & Neurotechnology
Mr. Spencer S. Stiles
Group President of Orthopaedics & Spine
Mr. William E. Berry Jr.
VP & Chief Accounting Officer
Mr. Robert C. Cohen
CTO and VP of Global R&D - Joint Replacement
Mr. Alan Douville
VP, Chief Information Officer & Chief Information Security Officer
Mr. Jason Beach
Vice President of Finance & Investor Relations
Mr. Robert S. Fletcher
VP & Chief Legal Officer

Important FAQs about investing in Stryker from India :

What is Stryker share price today?

Stryker share price today stands at $366.49, Open: $356.23 ; Previous Close: $364.60 ; High: $367.16 ; Low: $362.77 ; 52 Week High: $398.20 ; 52 Week Low: $292.43. The stock opens at $356.23, after a previous close of $364.60. The stock reached a daily high of $367.16 and a low of $362.77, with a 52-week high of $398.20 and a 52-week low of $292.43.

Can Indians buy Stryker shares?

Yes, Indians can invest in the Stryker (SYK) from India.

With INDmoney, you can buy Stryker at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Stryker at zero transaction cost.

How can I buy Stryker shares from India?

It is very easy to buy Stryker from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Stryker be purchased?

Yes, you can buy fractional shares of Stryker with INDmoney app.

What are the documents required to start investing in Stryker stocks?

To start investing in Stryker, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Stryker

Today’s highest price of Stryker (SYK) is $367.16.

Today’s lowest price of Stryker (SYK) is $362.77.

What is today's market capitalisation of Stryker

Today's market capitalisation of Stryker SYK is 136.1B

What is the 52 Week High and Low Range of Stryker

  • 52 Week High

    $398.20

  • 52 Week Low

    $292.43

What are the historical returns of Stryker?

  • 1 Month Returns

    -5.28%

  • 3 Months Returns

    7.38%

  • 1 Year Returns

    21.91%

  • 5 Years Returns

    73.83%

Who is the Chief Executive Officer (CEO) of Stryker

Mr. Kevin A. Lobo is the current Chief Executive Officer (CEO) of Stryker.